School and Graduate Institute of Physical Therapy of National Taiwan University
Taipei, Zhongzheng Dist, 100, Taiwan
NCT Number: NCT04802096
Inspiratory muscle weakness, limited functional exercise capacity and worse quality of life have been shown in patients with exacerbation of chronic obstructive pulmonary disease (COPD). Recommendations from clinical practice guideline state that promoting pulmonary rehabilitation after exacerbation can improve the conditions above. Inspiratory muscle training (IMT) has been proven to enhance inspiratory muscle strength and endurance in patient with stable COPD. However, there is less research on whether IMT in addition to pulmonary rehabilitation after exacerbation can benefit inspiratory muscle function, functional exercise capacity and quality of life in patients with COPD. The purpose of this study is to examine the effects of IMT in addition to pulmonary rehabilitation on respiratory muscle function, functional exercise capacity and quality of life in patients with exacerbation of chronic obstructive pulmonary disease.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Taipei, Zhongzheng Dist, 100, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intensity of inspiratory muscle training will be set at 30% of maximal inspiratory pressure. Subjects in intervention experimental group will perform 15 breaths per set, 6 sets per day on daily basis. The intervention will be last for 8 weeks.
Pulmonary rehabilitation consists of aerobic exercise training, strength training, and education related to airway clearance and drug utilization. All of subjects will receive 8-week pulmonary rehabilitation.
Time frame: 10 minutes
The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of diaphragm muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. Diaphragm activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGDia).
Time frame: 10 minutes
The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of SCM muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. SCM activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGSCM).
Time frame: 10 minutes
The power spectrum is divided into two equal areas of the frequency value by median frequency to exam muscle fatigue.
Time frame: Considering time of test and recovery, it will be expected to take totally 10 minutes.
Six-minute walking test will be performed to evaluate functional exercise capacity.
Time frame: 10 minutes
St. George's Respiratory Questionnaire and COPD assessment test will be used to evaluate quality of life.
National Taiwan University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04955080
Chronic Disease, Comorbidities and Coexisting Conditions
Enschede, Netherlands
View Trial DetailsNCT06801964
Exacerbation Copd, Lung Diseases
College Station, Texas, United States
View Trial DetailsNCT05779384
Chronic Disease, Disease Attributes
Kampala, Uganda
View Trial DetailsNCT05750810
COPD, Chronic Disease
Incheon, Gyeongki, South Korea
View Trial Details